Özge Demircan Tulacı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Özge Demircan Tulacı has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- Gül Ünsel-Bolat
Department of Child and Adolescent Psychiatry, Faculty of Medicine Balıkesir University Balıkesir Turkey
2 shared publications - Şahin Bodur
Department of Child and Adolescent Psychiatry, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey
2 shared publications - Abdullah Bozkurt
Department of Child and Adolescent Psychiatry, Konya Research and Training Hospital, Konya, Turkey
1 shared publication - Abdülbaki Artık
Child and Adolescent Psychiatry Department, Gulhane Training and Research Hospital University of Health Sciences Ankara Turkey
1 shared publication - Adnan Ozcetin
Department of Psychiatry, Duzce University School of Medicine, Duzce, Turkey
1 shared publication - Ahmet Bulent Yazici
Faculty of Medicine, Department of Psychiatry, Sakarya University, Sakarya, Turkey
1 shared publication
Latest Publications
- 30 October 2026
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 86 (7) , e70189
Emotional, Behavioural and Social Correlates in Subthreshold and Full‐Syndrome ADHD
Subthreshold attention‐deficit/hyperactivity disorder (ST‐ADHD) describes individuals who exhibit clinically significant symptoms of inattention, hyperactivity or impulsivity without meeting full diagnostic criteria for ADHD. Despite its subclinical status, ST‐ADHD may be associated with substantial emotional, behavioural and social impairment. This study aimed to compare children and adolescents with ST‐ADHD and full‐syndrome ADHD in terms of emotional and behavioural difficulties and psychiatric comorbidities. This cross‐sectional retrospective study included 217 patients with full‐syndrome ADHD and 111 with ST‐ADHD. Emotional, behavioural and social functioning were assessed using the Strengths and Difficulties Questionnaire (SDQ). Group differences were evaluated after controlling for potential confounding factors, including age, sex and education level. Interaction analyses were also performed to examine whether these differences varied by age or sex. Age distributions were comparable between the groups, although sex ratios and education levels differed. Psychiatric comorbidity was more prevalent in the ADHD group than in the ST‐ADHD group (74.2% vs. 60.4%, p = 0.010). In covariate‐adjusted analyses, hyperactivity/inattention scores remained significantly higher in the ADHD group, whereas emotional problems, conduct problems and peer‐related difficulties did not differ significantly between the groups. Formal interaction analyses did not show significant Group × Age or Group × Sex effects. The observed functional difficulties and relatively high comorbidity rates suggest that ST‐ADHD may represent a clinically relevant condition and that a dimensional assessment approach incorporating developmental and clinical characteristics may be useful. However, given the absence of a non‐ADHD comparison group, these results should be interpreted cautiously. Future studies including typically developing children and psychiatric comparison groups are needed to further clarify the specificity of these difficulties.
- 30 October 2026
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 86 (7) , e70189
Emotional, Behavioural and Social Correlates in Subthreshold and Full‐Syndrome ADHD
Subthreshold attention‐deficit/hyperactivity disorder (ST‐ADHD) describes individuals who exhibit clinically significant symptoms of inattention, hyperactivity or impulsivity without meeting full diagnostic criteria for ADHD. Despite its subclinical status, ST‐ADHD may be associated with substantial emotional, behavioural and social impairment. This study aimed to compare children and adolescents with ST‐ADHD and full‐syndrome ADHD in terms of emotional and behavioural difficulties and psychiatric comorbidities. This cross‐sectional retrospective study included 217 patients with full‐syndrome ADHD and 111 with ST‐ADHD. Emotional, behavioural and social functioning were assessed using the Strengths and Difficulties Questionnaire (SDQ). Group differences were evaluated after controlling for potential confounding factors, including age, sex and education level. Interaction analyses were also performed to examine whether these differences varied by age or sex. Age distributions were comparable between the groups, although sex ratios and education levels differed. Psychiatric comorbidity was more prevalent in the ADHD group than in the ST‐ADHD group (74.2% vs. 60.4%, p = 0.010). In covariate‐adjusted analyses, hyperactivity/inattention scores remained significantly higher in the ADHD group, whereas emotional problems, conduct problems and peer‐related difficulties did not differ significantly between the groups. Formal interaction analyses did not show significant Group × Age or Group × Sex effects. The observed functional difficulties and relatively high comorbidity rates suggest that ST‐ADHD may represent a clinically relevant condition and that a dimensional assessment approach incorporating developmental and clinical characteristics may be useful. However, given the absence of a non‐ADHD comparison group, these results should be interpreted cautiously. Future studies including typically developing children and psychiatric comparison groups are needed to further clarify the specificity of these difficulties.
- 14 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 110987
Eating behavior problems in children with epilepsy (6–16 years): A cross-sectional comparative study
- 14 March 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 179, 110987
Eating behavior problems in children with epilepsy (6–16 years): A cross-sectional comparative study
- Open Access
- 7 July 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (4) , 307-312
Social Workers in Pediatric Intensive Care Units: A Physician Perspective
Objective: The role of social workers, who are beginning to be integrated into the entire health system, is now becoming more and more understood. In our study, we aimed to discuss the duties of social workers at PICU, the results of their work in harmony with the physicians, and their importance for the intensive care team. Material and Methods: Sixtysix children aged between 1 month and 18 years old who were asked for social service consultation between January 2019 and December 2020 at our hospital’s PICU were included in the study. The age, diagnosis, sex, marital status (married-divorced), number of days of hospitalization, number of recurrent hospitalization, reason and result of consultation, necessity of psychiatric consultation and frequency of follow-up were retrospectively examined and recorded through the hospital information system. The collected data were analyzed by means of SPSS (version 22.0, SPSS Inc. Chicago, IL, USA). Results: The median age (months) (min-max) was found to be 172, 50 (6-209), and the median (min-max) duration of hospitalization (days) was found to be 2 (1-76). Family neglect was found to be the most common cause of social work indications (77.3%; n: 51). The number of patients who were given social counseling and referred to a psychiatrist was 25 (37.9%). Family neglect and abuse were detected in 5 (7.6%) patients. Apart from these, it was observed that problems such as drug supply, financial support, ID application, home device supply assistance, care center approvals and child custody were solved in each 1 (1.5%) patient. Conclusion: The inclusion of social workers in the children’s intensive care unit teams can also prevent many social problems that can be neglected otherwise. Physicians are more focused on patient treatment, so we believe that it will be beneficial to question the family and social status of patients together with a social service unit and specialists integrated into children’s intensive care units.
- 7 July 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (4) , 307-312
Open AccessSocial Workers in Pediatric Intensive Care Units: A Physician Perspective
Objective: The role of social workers, who are beginning to be integrated into the entire health system, is now becoming more and more understood. In our study, we aimed to discuss the duties of social workers at PICU, the results of their work in harmony with the physicians, and their importance for the intensive care team. Material and Methods: Sixtysix children aged between 1 month and 18 years old who were asked for social service consultation between January 2019 and December 2020 at our hospital’s PICU were included in the study. The age, diagnosis, sex, marital status (married-divorced), number of days of hospitalization, number of recurrent hospitalization, reason and result of consultation, necessity of psychiatric consultation and frequency of follow-up were retrospectively examined and recorded through the hospital information system. The collected data were analyzed by means of SPSS (version 22.0, SPSS Inc. Chicago, IL, USA). Results: The median age (months) (min-max) was found to be 172, 50 (6-209), and the median (min-max) duration of hospitalization (days) was found to be 2 (1-76). Family neglect was found to be the most common cause of social work indications (77.3%; n: 51). The number of patients who were given social counseling and referred to a psychiatrist was 25 (37.9%). Family neglect and abuse were detected in 5 (7.6%) patients. Apart from these, it was observed that problems such as drug supply, financial support, ID application, home device supply assistance, care center approvals and child custody were solved in each 1 (1.5%) patient. Conclusion: The inclusion of social workers in the children’s intensive care unit teams can also prevent many social problems that can be neglected otherwise. Physicians are more focused on patient treatment, so we believe that it will be beneficial to question the family and social status of patients together with a social service unit and specialists integrated into children’s intensive care units.
- 30 June 2022
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 9 (2) , 305-309
Current Situation in Planning and Evaluation of Etiological Genetic Tests in Children with Developmental Delay/Intellectual Disability: Single Center Experience
Giriş ve Amaç: Gelişim geriliği (GG) ve entelektüel yetersizlik (EY) fenotipik ve genetik olarak heterojen bir grup hastalıktır. GG/EY olguların etiyolojisinde altta yatan önemli bir kısmını genetik nedenler oluşturmaktadır. Bu araştırmadaki amacımız, GG/EY tanısı olan olguların genetik tanılama oranlarına ilişkin verilerin araştırılmasıydı. Gereç ve Yöntemler: GG/EY ön tanısıyla Ocak 2020 ile Aralık 2020 tarihleri arasında gelişim testlerine yönlendirilen 0-6 yaş arasında 578 olgunun hastane kayıtları retrospektif incelendi. Bu olgulara yönelik yapılan genetik testlerin sonuçları değerlendirmeye alındı. Bulgular: Yapılan gelişim testi sonucunda GG/EY saptanan olguların oranı %68,3 idi. GG/EY tanısı alan olguların içerisinde genetik polikliniğine başvuruda bulunan olguların oranı ise %7,4 idi. Uygulanan genetik testler sonucunda GG/EY ile ilişkili genetik varyant saptanma oranı %37,9 idi. Sonuç: Nörogelişimsel bozukluklarda genetik değerlendirme ve genetik testlere ulaşıma ilişkin kısıtlılıklar tüm dünyada önemli bir sorun olarak karşımıza çıkmaktadır. Çalışmamızda GG/EY olgularının genetiğe yönlendirme oranı ulaşılabilir birçok ülke verileri ile kıyaslandığında düşük olarak saptanmıştır. Ülkemizde GG/EY tanılı olgular için uygun genetik danışmanlığı sağlamak, prognozu belirleyebilmek ve gelecek nesillere yönelik birincil koruma sağlayabilmek için ülke genelinde uygulanabilecek sağlık politikalarına ihtiyaç duyulmaktadır.
- 30 June 2022
- Published by Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 9 (2) , 305-309
Current Situation in Planning and Evaluation of Etiological Genetic Tests in Children with Developmental Delay/Intellectual Disability: Single Center Experience
Giriş ve Amaç: Gelişim geriliği (GG) ve entelektüel yetersizlik (EY) fenotipik ve genetik olarak heterojen bir grup hastalıktır. GG/EY olguların etiyolojisinde altta yatan önemli bir kısmını genetik nedenler oluşturmaktadır. Bu araştırmadaki amacımız, GG/EY tanısı olan olguların genetik tanılama oranlarına ilişkin verilerin araştırılmasıydı. Gereç ve Yöntemler: GG/EY ön tanısıyla Ocak 2020 ile Aralık 2020 tarihleri arasında gelişim testlerine yönlendirilen 0-6 yaş arasında 578 olgunun hastane kayıtları retrospektif incelendi. Bu olgulara yönelik yapılan genetik testlerin sonuçları değerlendirmeye alındı. Bulgular: Yapılan gelişim testi sonucunda GG/EY saptanan olguların oranı %68,3 idi. GG/EY tanısı alan olguların içerisinde genetik polikliniğine başvuruda bulunan olguların oranı ise %7,4 idi. Uygulanan genetik testler sonucunda GG/EY ile ilişkili genetik varyant saptanma oranı %37,9 idi. Sonuç: Nörogelişimsel bozukluklarda genetik değerlendirme ve genetik testlere ulaşıma ilişkin kısıtlılıklar tüm dünyada önemli bir sorun olarak karşımıza çıkmaktadır. Çalışmamızda GG/EY olgularının genetiğe yönlendirme oranı ulaşılabilir birçok ülke verileri ile kıyaslandığında düşük olarak saptanmıştır. Ülkemizde GG/EY tanılı olgular için uygun genetik danışmanlığı sağlamak, prognozu belirleyebilmek ve gelecek nesillere yönelik birincil koruma sağlayabilmek için ülke genelinde uygulanabilecek sağlık politikalarına ihtiyaç duyulmaktadır.
- 23 March 2022
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 210 (8) , 570-576
Obsessive-Compulsive Disorder During the Initial Stage of COVID-19 Pandemic
We aimed to investigate the effect of the COVID-19 pandemic on the symptom severity and dimensions of obsessive-compulsive disorder (OCD) and how patients with different levels of insight have been impacted by the pandemic. This study included 58 patients with OCD. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS)–Obsession, Y-BOCS–Compulsion, and Y-BOCS–Total scores during the pandemic were significantly higher than the prepandemic scores (p = 0.001, p < 0.001, p = 0.002, respectively). Compared with the pre-COVID-19 period, severity of OCD symptoms increased in 39.7% patients, remained the same in 44.8% patients, and reduced in 15.5% patients during the pandemic. The obsession with contamination, Brown Assessment of Beliefs Scale (for insight assessment) score, and time spent following the news/data about COVID-19 were significantly associated with an increase in OCD severity. In patients with contamination obsessions as well as poor insight, close monitoring and facilitating access to treatment may reduce the negative impact of the COVID-19 pandemic.
- 23 March 2022
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 210 (8) , 570-576
Obsessive-Compulsive Disorder During the Initial Stage of COVID-19 Pandemic
We aimed to investigate the effect of the COVID-19 pandemic on the symptom severity and dimensions of obsessive-compulsive disorder (OCD) and how patients with different levels of insight have been impacted by the pandemic. This study included 58 patients with OCD. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS)–Obsession, Y-BOCS–Compulsion, and Y-BOCS–Total scores during the pandemic were significantly higher than the prepandemic scores (p = 0.001, p < 0.001, p = 0.002, respectively). Compared with the pre-COVID-19 period, severity of OCD symptoms increased in 39.7% patients, remained the same in 44.8% patients, and reduced in 15.5% patients during the pandemic. The obsession with contamination, Brown Assessment of Beliefs Scale (for insight assessment) score, and time spent following the news/data about COVID-19 were significantly associated with an increase in OCD severity. In patients with contamination obsessions as well as poor insight, close monitoring and facilitating access to treatment may reduce the negative impact of the COVID-19 pandemic.
- Open Access
- 30 December 2021
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 23 (3) , 263-269
Evaluation of Serum S100B Levels in Male Children Younger than 6 Years Old with Autism Spectrum Disorder: A Psychiatric and Biochemical Perspective
Aim: Autism spectrum disorder is a neurodevelopmental disorder. The S100 calcium binding protein B (S100B) is among the markers of astrocyte activation as well as brain damage. Herein, it was aimed to evaluate S100B levels to determine whether there is a relation with the severity of autism spectrum disorder and establish possible causes of different results among the studies in the literature from a psychiatric and biochemical perspective. Material and Methods: Twenty-five male children with autism spectrum disorder were included as the study group along with twenty-seven male children as the control group. The childhood autism rating scale and the autism behavior checklist were applied. Serum S100B protein levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: The mean serum S100B level was 1008.61±171.34 pg/mL in the study group and 1060.14±182.83 pg/mL in the control group, and no statistically significant difference was found between the groups (p=0.300). Based on the childhood autism rating scale scores, 60% (n=15) of the children with autism spectrum disorder had severe autism, whereas 40% (n=10) had mild-to-moderate autism. There was no significant difference in terms of the serum S100B levels between the groups of autism spectrum disorder severity (p=0.935) or according to the autistic regression status (p=0.667). Conclusion: For S100B to be accepted as a reliable biomarker for autism spectrum disorder, more studies considering some factors with larger samples should be performed. Moreover, to understand the effect of biochemical methodology on the results, further studies are suggested on this subject.
- 30 December 2021
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 23 (3) , 263-269
Open AccessEvaluation of Serum S100B Levels in Male Children Younger than 6 Years Old with Autism Spectrum Disorder: A Psychiatric and Biochemical Perspective
Aim: Autism spectrum disorder is a neurodevelopmental disorder. The S100 calcium binding protein B (S100B) is among the markers of astrocyte activation as well as brain damage. Herein, it was aimed to evaluate S100B levels to determine whether there is a relation with the severity of autism spectrum disorder and establish possible causes of different results among the studies in the literature from a psychiatric and biochemical perspective. Material and Methods: Twenty-five male children with autism spectrum disorder were included as the study group along with twenty-seven male children as the control group. The childhood autism rating scale and the autism behavior checklist were applied. Serum S100B protein levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: The mean serum S100B level was 1008.61±171.34 pg/mL in the study group and 1060.14±182.83 pg/mL in the control group, and no statistically significant difference was found between the groups (p=0.300). Based on the childhood autism rating scale scores, 60% (n=15) of the children with autism spectrum disorder had severe autism, whereas 40% (n=10) had mild-to-moderate autism. There was no significant difference in terms of the serum S100B levels between the groups of autism spectrum disorder severity (p=0.935) or according to the autistic regression status (p=0.667). Conclusion: For S100B to be accepted as a reliable biomarker for autism spectrum disorder, more studies considering some factors with larger samples should be performed. Moreover, to understand the effect of biochemical methodology on the results, further studies are suggested on this subject.
- Open Access
- 30 April 2018
- Published by AVES YAYINCILIK A.Ş. in Psychiatry and Clinical Psychopharmacology
- Vol. 28 (sup1) , 297-391
Symposium Oral Presentations
(2018). Symposium Oral Presentations. Psychiatry and Clinical Psychopharmacology: Vol. 28, 10th International Congress on Psychopharmacology & 6th International Symposium on Child and Adolescent Psychopharmacology 2018 Abstracts, pp. 297-391.
- 30 April 2018
- Published by AVES YAYINCILIK A.Ş. in Psychiatry and Clinical Psychopharmacology
- Vol. 28 (sup1) , 297-391
Open AccessSymposium Oral Presentations
(2018). Symposium Oral Presentations. Psychiatry and Clinical Psychopharmacology: Vol. 28, 10th International Congress on Psychopharmacology & 6th International Symposium on Child and Adolescent Psychopharmacology 2018 Abstracts, pp. 297-391.